|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
113,340,000 |
Market
Cap: |
126.94(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.6758 - $2.59 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Karyopharm Therapeutics is a pharmaceutical company focused on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Co.'s main asset, XPOVIO® (selinexor), a Selective Inhibitors of Nuclear Export compound, is indicated for use in adult patients with multiple myeloma who have received at least one prior therapy; adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
41,140 |
41,140 |
Total Buy Value |
$0 |
$0 |
$49,985 |
$49,985 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
245,339 |
267,139 |
312,283 |
979,563 |
Total Sell Value |
$289,577 |
$316,630 |
$384,544 |
$4,272,335 |
Total People Sold |
6 |
6 |
6 |
8 |
Total Sell Transactions |
17 |
22 |
34 |
59 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shacham Sharon |
President & CSO |
|
2018-04-18 |
4 |
OE |
$0.26 |
$2,640 |
I/I |
10,000 |
522,143 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-04-09 |
4 |
AS |
$12.48 |
$124,829 |
I/I |
(10,000) |
713,510 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-04-09 |
4 |
OE |
$0.26 |
$2,640 |
I/I |
10,000 |
723,510 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-04-09 |
4 |
AS |
$12.48 |
$124,829 |
D/D |
(10,000) |
713,510 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-04-09 |
4 |
OE |
$0.26 |
$2,640 |
D/D |
10,000 |
723,510 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-03-19 |
4 |
AS |
$15.29 |
$152,895 |
D/D |
(10,000) |
512,143 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-03-19 |
4 |
OE |
$0.26 |
$2,640 |
D/D |
10,000 |
522,143 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-03-19 |
4 |
AS |
$15.29 |
$152,895 |
I/I |
(10,000) |
512,143 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-03-19 |
4 |
OE |
$0.26 |
$2,640 |
I/I |
10,000 |
522,143 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2018-03-12 |
4 |
AS |
$17.01 |
$42,525 |
D/D |
(2,500) |
0 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2018-03-12 |
4 |
OE |
$0.26 |
$660 |
D/D |
2,500 |
2,500 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-03-07 |
4 |
AS |
$16.15 |
$161,463 |
I/I |
(10,000) |
713,510 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-03-07 |
4 |
OE |
$0.26 |
$2,640 |
I/I |
10,000 |
723,510 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-03-07 |
4 |
AS |
$16.15 |
$161,463 |
D/D |
(10,000) |
713,510 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-03-07 |
4 |
OE |
$0.26 |
$2,640 |
D/D |
10,000 |
723,510 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2018-03-05 |
4 |
AS |
$16.00 |
$40,000 |
D/D |
(2,500) |
0 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2018-03-05 |
4 |
OE |
$0.26 |
$660 |
D/D |
2,500 |
2,500 |
|
- |
|
Primiano Christopher Brett |
EVP, CBO, GC & Secretary |
|
2018-03-05 |
4 |
AS |
$16.03 |
$40,076 |
D/D |
(2,500) |
4,881 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-02-20 |
4 |
AS |
$14.79 |
$147,872 |
D/D |
(10,000) |
512,143 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-02-20 |
4 |
OE |
$0.26 |
$2,640 |
D/D |
10,000 |
522,143 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-02-20 |
4 |
AS |
$14.79 |
$147,872 |
I/I |
(10,000) |
512,143 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-02-20 |
4 |
OE |
$0.26 |
$2,640 |
I/I |
10,000 |
522,143 |
|
- |
|
Primiano Christopher Brett |
EVP, CBO, GC & Secretary |
|
2018-02-16 |
4 |
AS |
$15.01 |
$22,298 |
D/D |
(1,486) |
7,381 |
|
- |
|
Primiano Christopher Brett |
EVP, CBO, GC & Secretary |
|
2018-02-15 |
4 |
AS |
$15.02 |
$15,229 |
D/D |
(1,014) |
8,867 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2018-02-08 |
4 |
AS |
$14.00 |
$21,000 |
D/D |
(1,500) |
0 |
|
- |
|
592 Records found
|
|
Page 18 of 24 |
|
|